Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease
Open Access
- 25 January 2000
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 14 (2) , 247-254
- https://doi.org/10.1038/sj.leu.2401669
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Minimal residual disease detection in B-cell malignanciesby assessing IgH rearrangementHematology and Cell Therapy, 1997
- Identification of a variable number tandem repeat region in the human T cell receptor alpha-delta (TCRAD) locusHuman Genetics, 1996
- HLA-Identical Sibling Bone Marrow Transplantation in Younger Patients with Chronic Lymphocytic LeukemiaAnnals of Internal Medicine, 1996
- Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology eraLeukemia Research, 1995
- Serum levels of tumour necrosis factor-α in patients with B-cell chronic lymphocytic leukaemiaEuropean Journal Of Cancer, 1994
- Isolation, localization, and physical mapping of a highly polymorphic locus on human chromosome 11q13Genomics, 1991
- Rapid Detection of Hypervariable Regions by the Polymerase Chain Reaction TechniqueDNA and Cell Biology, 1990
- Amplification of a hightly polymorphic VNTR segment by the polymerase chain reactionNucleic Acids Research, 1989
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer, 1981